OBJECTIVE: A growing body of data suggests that a significantly enhanced salivary cortisol response to waking may indicate an enduring tendency to abnormal cortisol regulation. Our objective was to apply the response test to a population already known to have long-term hypothalamo-pituitary-adrenocortical (HPA) axis dysregulation. We hypothesized that the free cortisol response to waking, believed to be genetically influenced, would be elevated in a significant percentage of cases, regardless of the afternoon Dexamethasone Suppression Test (DST) value. METHOD: Using the free cortisol response to waking and the short daytime profile, we tested 18 clinically stable, lithium-responsive subjects from our long-term naturalistic follow-up of monthly DSTs. These tests include salivary testing every 15 minutes during the first hour of waking, followed by samples taken at 3:00 PM and 8:00 PM. RESULTS: While clinically stable on lithium prophylaxis, patients with bipolar disorder (BD) showed a significantly enhanced salivary cortisol response to waking, compared with control subjects (P < 0.03). Cortisol levels 30 minutes after waking significantly exceeded those in the large normative data provided in the literature (P < 0.001). CONCLUSIONS: Our observations support the hypothesis that the free cortisol response to waking can reflect relatively enduring HPA dysregulation, even when lithium-responsive BD patients are clinically well and their DSTs are normal. Because the test is easy to administer, the free cortisol response to waking may hold promise as a marker in studies of high-risk families predisposed to, or at risk for, mood disorders.
OBJECTIVE: A growing body of data suggests that a significantly enhanced salivary cortisol response to waking may indicate an enduring tendency to abnormal cortisol regulation. Our objective was to apply the response test to a population already known to have long-term hypothalamo-pituitary-adrenocortical (HPA) axis dysregulation. We hypothesized that the free cortisol response to waking, believed to be genetically influenced, would be elevated in a significant percentage of cases, regardless of the afternoon Dexamethasone Suppression Test (DST) value. METHOD: Using the free cortisol response to waking and the short daytime profile, we tested 18 clinically stable, lithium-responsive subjects from our long-term naturalistic follow-up of monthly DSTs. These tests include salivary testing every 15 minutes during the first hour of waking, followed by samples taken at 3:00 PM and 8:00 PM. RESULTS: While clinically stable on lithium prophylaxis, patients with bipolar disorder (BD) showed a significantly enhanced salivary cortisol response to waking, compared with control subjects (P < 0.03). Cortisol levels 30 minutes after waking significantly exceeded those in the large normative data provided in the literature (P < 0.001). CONCLUSIONS: Our observations support the hypothesis that the free cortisol response to waking can reflect relatively enduring HPA dysregulation, even when lithium-responsive BDpatients are clinically well and their DSTs are normal. Because the test is easy to administer, the free cortisol response to waking may hold promise as a marker in studies of high-risk families predisposed to, or at risk for, mood disorders.
Authors: Leandro L Valiengo; Márcio G Soeiro-de-Souza; Andrea H Marques; Doris H Moreno; Mário F Juruena; Ana Cristina Andreazza; Wagner F Gattaz; Rodrigo Machado-Vieira Journal: J Affect Disord Date: 2012-02-02 Impact factor: 4.839
Authors: Haroon I Sheikh; Lea R Dougherty; Elizabeth P Hayden; Daniel N Klein; Shiva M Singh Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2010-05-16 Impact factor: 5.067
Authors: Masoud Kamali; Erika F H Saunders; Alan R Prossin; Christine B Brucksch; Gloria J Harrington; Scott A Langenecker; Melvin G McInnis Journal: J Affect Disord Date: 2011-12-10 Impact factor: 4.839
Authors: Marieke J van der Werf-Eldering; Rixt F Riemersma-van der Lek; Huibert Burger; Esther A E Holthausen; André Aleman; Willem A Nolen Journal: PLoS One Date: 2012-05-14 Impact factor: 3.240
Authors: Karlijn Becking; Annet T Spijker; Erik Hoencamp; Brenda W J H Penninx; Robert A Schoevers; Lynn Boschloo Journal: PLoS One Date: 2015-07-21 Impact factor: 3.240